Reported benefits (per available research): Studied for restoring more youthful pulsatile GH and IGF-1 secretion in older adults, based on a small 1997 randomized, placebo-controlled human trial of a closely related GHRH(1-29) analog published in the Journal of Clinical Endocrinology & Metabolism May support gains in lean body mass in men specifically: that same 16-week trial found a statistically significant increase in lean body mass in men but not in women, alongside a significant increase in skin thickness (a marker of dermal collagen) in both sexes Proposed to support broader recovery and body-composition goals tied to growth-hormone-axis activity, though sermorelin-specific modern adult trial data remains thin, and much of the anti-aging and muscle-building framing used in commercial marketing outpaces the current clinical evidence base Known risks and side effects: Injection-site reactions (pain, swelling, or redness) are the most commonly reported adverse event associated with sermorelin therapy in manufacturer drug-labeling data Headache, flushing, dizziness, difficulty swallowing, hyperactivity, drowsiness, and hives have also been reported less commonly per that same labeling data

Research demonstrates topical or systemic thymosin beta-4 administration increases reepithelialization by 42-61% compared to controls at various time points post-wounding
Nutrient absorption, hormone metabolism, and systemic inflammation levels are all regulated through gut function
Dosage Forms Products (Compounded) Low Dose Naltrexone Discover the Transformative Potential of Low Dose Naltrexone (LDN) Unlock a new horizon in treatment with Low Dose Naltrexone (LDN), a novel approach to managing a variety of chronic conditions with an excellent safety profile
IGF-1 and Hormone Optimization One of the most significant advantages of IGF-1 therapy is its synergistic relationship with other hormones